Share this @internewscast.com

The first over-the-counter birth control pill will be available on pharmacy and store shelves nationwide and online later this month, and will cost about $20 for a 30-day supply, Perrigo, its manufacturer announced on Monday.

Now available for pre-order from some online retailers, the product, Opill, was approved by the U.S. Food and Drug Administration for OTC use for all ages in July, making it the first daily birth control cleared for sale without a prescription in the U.S. 

The product will come in a variety of sizes, including one-month three-month and six-month packs, with suggested retail prices of $19.99, $49.99 and $89.99, respectively, according to Perrigo.

The company plans to offer a cost-assistance program in coming weeks to help qualified low-income, uninsured individuals obtain the product at low or no cost, it said. 

First approved by the FDA in 1973 to be used as a prescription drug, HRA Pharma, a subsidiary of Perrigo, acquired the rights to Opill from Pfizer in 2014.

“Progestin-only pills have been a trusted contraceptive option for decades, yet obtaining a prescription for birth control pills creates unnecessary barriers for many,” Dr. Melissa J. Kottke, stated in a news release. 


Opill will be first over-the-counter birth control pill sold in stores

02:05

“Creating additional opportunities for contraceptive access is critical in helping people reach their reproductive goals, added the Atlanta-based obstetrician-gynecologist, who served as a paid consultant to Perrigo during the FDA approval process.

The product is 98% effective when taken as directed, according to the consumer products company, headquartered in Dublin, Ireland, and Grand Rapids, Michigan. 

Almost half of the 6.1 million pregnancies in the U.S. each year are unintended, according to the FDA.

Share this @internewscast.com
You May Also Like

UK Mother Battling Rare Lung Cancer to Receive Groundbreaking Surgery

Natasha Loveridge (Image: SWNS) EXCLUSIVE EXCLUSIVE A mother grappling with a rare…

Comprehensive Insight into Upcoming ‘Ozempic Pills’: A Variety of Options on the Horizon with Promising Early Evidence, According to Dr. Brad McKay

In the late ’90s, as a budding medical student at Monash University…

Uncover the Overlooked Symptom: How a Common Cold Sign Could Signal Breast Cancer

Although many are familiar with breast cancer symptoms that appear directly in…

Palliative Care Expert Reveals Top Three Wishes of Patients Facing End of Life

End-of-life care is a profound period that often brings clarity and reflection…

Enhance Your Energy: 30-Minute Daily Adjustment Boosts Metabolism

New research suggests that reducing daily sitting time by just 30 minutes…

Women Targeted in ‘Menopause Gold Rush’: How Lack of Official Guidance Fuels Exploitative Practices

Research indicates that women are falling victim to a “menopause gold rush,”…

How Mounjaro Transformed My Life: From 19 Stone and Addiction to a £200,000 Savings Miracle

Rachel Cooper, aiming to shed the extra weight gained during the Covid-19…

The Hidden Struggles: How Common Antidepressants Can Turn Life Unbearable for Millions

Lexapro stands as the second most prescribed antidepressant in the United States,…

Is Your Stress More Than It Seems? Early Dementia Symptoms You Shouldn’t Ignore

In today’s fast-paced world, it’s not unusual to forget to send an…

Nutritionist Unveils Vitamin-Rich ‘Heal Me’ Chicken Soup Recipe

As winter’s chill grips the UK, the familiar wave of coughs, colds,…

Prostate Cancer Screening: Weighing the Pros and Cons – Why Some Doctors Advise Against Mass Testing and Who Should Consider It

The suggestion seems straightforward enough: regularly screen middle-aged men for prostate cancer,…